Global Endometriosis Market Research Report 2023(Status and Outlook)

Global Endometriosis Market Research Report 2023(Status and Outlook)



Report Overview

Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.

Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness amongst patients and physicians. In addition, considerable research efforts towards development of novel non hormonal drugs, diagnostic and surgical techniques coupled with substantial support in terms of funding has helped to further enhance the growth of this market. Therefore, huge unmet needs for curative treatment of endometriosis will serve this market as a potential opportunity. The growth in global endometriosis market will be primarily driven by emerging Asian economies, where the disease prevalence is almost 10% of the total female population of this region.

The Global Endometriosis Market Size was estimated at USD 1515.70 million in 2022 and is projected to reach USD 1670.62 million by 2029, exhibiting a CAGR of 1.40% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Endometriosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Endometriosis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Endometriosis market in any manner.

Global Endometriosis Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AbbVie

AstraZeneca

Bayer HealthCare

Pfizer

Addex Therapeutics

Astellas Pharma

Debiopharm

ElexoPharm

EndoCeutics

Euroscreen

Forendo Pharma

Kissei Pharmaceutical

Neurocrine Biosciences

Nippon Shinyaku

Takeda

Bayer AG

Neurocrine Biosciences

Market Segmentation (by Type)

Gonadotropins Releasing Hormone Agonists

Non-Steroidal Anti-Inflammatory Drugs

Progestin

Oral Contraceptive Pills

Market Segmentation (by Application)

Food

Beverages

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Endometriosis Market

Overview of the regional outlook of the Endometriosis Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Endometriosis
1.2 Key Market Segments
1.2.1 Endometriosis Segment by Type
1.2.2 Endometriosis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Endometriosis Market Overview
2.1 Global Market Overview
2.1.1 Global Endometriosis Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Endometriosis Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Endometriosis Market Competitive Landscape
3.1 Global Endometriosis Sales by Manufacturers (2018-2023)
3.2 Global Endometriosis Revenue Market Share by Manufacturers (2018-2023)
3.3 Endometriosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Endometriosis Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Endometriosis Sales Sites, Area Served, Product Type
3.6 Endometriosis Market Competitive Situation and Trends
3.6.1 Endometriosis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Endometriosis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Endometriosis Industry Chain Analysis
4.1 Endometriosis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Endometriosis Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Endometriosis Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Endometriosis Sales Market Share by Type (2018-2023)
6.3 Global Endometriosis Market Size Market Share by Type (2018-2023)
6.4 Global Endometriosis Price by Type (2018-2023)
7 Endometriosis Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Endometriosis Market Sales by Application (2018-2023)
7.3 Global Endometriosis Market Size (M USD) by Application (2018-2023)
7.4 Global Endometriosis Sales Growth Rate by Application (2018-2023)
8 Endometriosis Market Segmentation by Region
8.1 Global Endometriosis Sales by Region
8.1.1 Global Endometriosis Sales by Region
8.1.2 Global Endometriosis Sales Market Share by Region
8.2 North America
8.2.1 North America Endometriosis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Endometriosis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Endometriosis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Endometriosis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Endometriosis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AbbVie
9.1.1 AbbVie Endometriosis Basic Information
9.1.2 AbbVie Endometriosis Product Overview
9.1.3 AbbVie Endometriosis Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Endometriosis SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Endometriosis Basic Information
9.2.2 AstraZeneca Endometriosis Product Overview
9.2.3 AstraZeneca Endometriosis Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Endometriosis SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bayer HealthCare
9.3.1 Bayer HealthCare Endometriosis Basic Information
9.3.2 Bayer HealthCare Endometriosis Product Overview
9.3.3 Bayer HealthCare Endometriosis Product Market Performance
9.3.4 Bayer HealthCare Business Overview
9.3.5 Bayer HealthCare Endometriosis SWOT Analysis
9.3.6 Bayer HealthCare Recent Developments
9.4 Pfizer
9.4.1 Pfizer Endometriosis Basic Information
9.4.2 Pfizer Endometriosis Product Overview
9.4.3 Pfizer Endometriosis Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Endometriosis SWOT Analysis
9.4.6 Pfizer Recent Developments
9.5 Addex Therapeutics
9.5.1 Addex Therapeutics Endometriosis Basic Information
9.5.2 Addex Therapeutics Endometriosis Product Overview
9.5.3 Addex Therapeutics Endometriosis Product Market Performance
9.5.4 Addex Therapeutics Business Overview
9.5.5 Addex Therapeutics Endometriosis SWOT Analysis
9.5.6 Addex Therapeutics Recent Developments
9.6 Astellas Pharma
9.6.1 Astellas Pharma Endometriosis Basic Information
9.6.2 Astellas Pharma Endometriosis Product Overview
9.6.3 Astellas Pharma Endometriosis Product Market Performance
9.6.4 Astellas Pharma Business Overview
9.6.5 Astellas Pharma Recent Developments
9.7 Debiopharm
9.7.1 Debiopharm Endometriosis Basic Information
9.7.2 Debiopharm Endometriosis Product Overview
9.7.3 Debiopharm Endometriosis Product Market Performance
9.7.4 Debiopharm Business Overview
9.7.5 Debiopharm Recent Developments
9.8 ElexoPharm
9.8.1 ElexoPharm Endometriosis Basic Information
9.8.2 ElexoPharm Endometriosis Product Overview
9.8.3 ElexoPharm Endometriosis Product Market Performance
9.8.4 ElexoPharm Business Overview
9.8.5 ElexoPharm Recent Developments
9.9 EndoCeutics
9.9.1 EndoCeutics Endometriosis Basic Information
9.9.2 EndoCeutics Endometriosis Product Overview
9.9.3 EndoCeutics Endometriosis Product Market Performance
9.9.4 EndoCeutics Business Overview
9.9.5 EndoCeutics Recent Developments
9.10 Euroscreen
9.10.1 Euroscreen Endometriosis Basic Information
9.10.2 Euroscreen Endometriosis Product Overview
9.10.3 Euroscreen Endometriosis Product Market Performance
9.10.4 Euroscreen Business Overview
9.10.5 Euroscreen Recent Developments
9.11 Forendo Pharma
9.11.1 Forendo Pharma Endometriosis Basic Information
9.11.2 Forendo Pharma Endometriosis Product Overview
9.11.3 Forendo Pharma Endometriosis Product Market Performance
9.11.4 Forendo Pharma Business Overview
9.11.5 Forendo Pharma Recent Developments
9.12 Kissei Pharmaceutical
9.12.1 Kissei Pharmaceutical Endometriosis Basic Information
9.12.2 Kissei Pharmaceutical Endometriosis Product Overview
9.12.3 Kissei Pharmaceutical Endometriosis Product Market Performance
9.12.4 Kissei Pharmaceutical Business Overview
9.12.5 Kissei Pharmaceutical Recent Developments
9.13 Neurocrine Biosciences
9.13.1 Neurocrine Biosciences Endometriosis Basic Information
9.13.2 Neurocrine Biosciences Endometriosis Product Overview
9.13.3 Neurocrine Biosciences Endometriosis Product Market Performance
9.13.4 Neurocrine Biosciences Business Overview
9.13.5 Neurocrine Biosciences Recent Developments
9.14 Nippon Shinyaku
9.14.1 Nippon Shinyaku Endometriosis Basic Information
9.14.2 Nippon Shinyaku Endometriosis Product Overview
9.14.3 Nippon Shinyaku Endometriosis Product Market Performance
9.14.4 Nippon Shinyaku Business Overview
9.14.5 Nippon Shinyaku Recent Developments
9.15 Takeda
9.15.1 Takeda Endometriosis Basic Information
9.15.2 Takeda Endometriosis Product Overview
9.15.3 Takeda Endometriosis Product Market Performance
9.15.4 Takeda Business Overview
9.15.5 Takeda Recent Developments
9.16 Bayer AG
9.16.1 Bayer AG Endometriosis Basic Information
9.16.2 Bayer AG Endometriosis Product Overview
9.16.3 Bayer AG Endometriosis Product Market Performance
9.16.4 Bayer AG Business Overview
9.16.5 Bayer AG Recent Developments
9.17 Neurocrine Biosciences
9.17.1 Neurocrine Biosciences Endometriosis Basic Information
9.17.2 Neurocrine Biosciences Endometriosis Product Overview
9.17.3 Neurocrine Biosciences Endometriosis Product Market Performance
9.17.4 Neurocrine Biosciences Business Overview
9.17.5 Neurocrine Biosciences Recent Developments
10 Endometriosis Market Forecast by Region
10.1 Global Endometriosis Market Size Forecast
10.2 Global Endometriosis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Endometriosis Market Size Forecast by Country
10.2.3 Asia Pacific Endometriosis Market Size Forecast by Region
10.2.4 South America Endometriosis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Endometriosis by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Endometriosis Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Endometriosis by Type (2024-2029)
11.1.2 Global Endometriosis Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Endometriosis by Type (2024-2029)
11.2 Global Endometriosis Market Forecast by Application (2024-2029)
11.2.1 Global Endometriosis Sales (K MT) Forecast by Application
11.2.2 Global Endometriosis Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings